Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

XSSC:688505 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
10 Dec 24	SellCN¥14,946,214	Chong Mang Ieong	Individual		1,714,015	CN¥8.72

Insider Trading Volume

Insider Buying: 688505 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 688505?
Owner Type	Number of Shares	Ownership Percentage
Institutions	38,348,396	3.7%
VC/PE Firms	156,892,912	15.1%
Public Companies	210,142,560	20.3%
Individual Insiders	266,675,430	25.7%
General Public	364,512,802	35.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 64.83% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
20.3%	Shanghai Pharmaceuticals Holding Co., Ltd	210,142,560	CN¥1.3b	-25.1%	no data
15.1%	China New Enterprise Investment Co., Ltd.	156,892,912	CN¥990.9m	0%	no data
7.72%	Zong Meng Yang	80,000,000	CN¥505.3m	0%	no data
7.52%	Chong Mang Ieong	77,958,092	CN¥492.4m	0%	no data
5.58%	Hai Bo Wang	57,886,430	CN¥365.6m	0%	no data
1.78%	Yong Su	18,477,860	CN¥116.7m	0%	no data
1.56%	Invesco Ltd.	16,160,000	CN¥102.1m	0%	no data
1.51%	Da Jun Zhao	15,620,710	CN¥98.7m	0%	no data
0.87%	Jun Li	9,018,200	CN¥57.0m	0%	no data
0.63%	Shanghai Pudong Science and Technology Investment Co., Ltd.	6,562,382	CN¥41.4m	0%	1.36%
0.63%	Shanghai Pudong Emerging Industry Investment Co., Ltd.	6,562,382	CN¥41.4m	0%	no data
0.44%	Gfund Management Co., Ltd.	4,532,842	CN¥28.6m	0%	0.14%
0.28%	Dimensional Fund Advisors LP	2,906,014	CN¥18.4m	0%	no data
0.2%	Xue Yan	2,030,000	CN¥12.8m	0%	no data
0.18%	Xiaolin Yang	1,845,688	CN¥11.7m	0%	no data
0.15%	Yi Min Gan	1,572,850	CN¥9.9m	0%	no data
0.11%	Luo Chun Wang	1,170,000	CN¥7.4m	0%	no data
0.1%	Fullgoal Fund Management Co. Ltd.	1,062,144	CN¥6.7m	0%	no data
0.064%	Dai Qing Yu	664,000	CN¥4.2m	0%	no data
0.025%	E Fund Management Co., Ltd.	261,407	CN¥1.7m	0%	no data
0.02%	Xiaowen Li	210,000	CN¥1.3m	0%	no data
0.018%	Yu Chen	182,600	CN¥1.2m	0%	no data
0.012%	Penghua Fund Management Co., Ltd.	128,815	CN¥813.8k	0%	no data
0.0075%	Tebon Fund Management Co. Ltd.	77,700	CN¥491.0k	0%	0.01%
0.0038%	Ya Nan Qu	39,000	CN¥246.2k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/19 11:12
End of Day Share Price	2024/12/19 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jack Hu	Deutsche Bank
Feng Qiang Sun	Guotai Junan International Holdings Limited
Xiang Jun	Industrial Securities Co. Ltd.